Universal Health Realty me Trust(US:UHT)2024-05-08 20:20Real Estate Investments - As of May 1, 2024, the company has 76 real estate investments or commitments located in 21 states, including 6 hospital facilities and 60 medical/office buildings[96]. Revenue and Income - Approximately 41% of the company's consolidated revenues for the three-month period ended March 31, 2024, were derived from UHS, highlighting a significant dependency on this operator[101]. - Net income for the three-month period ended March 31, 2024, was $5.3 million, an increase of $841,000 compared to $4.5 million in the same period of 2023[110]. - Revenues increased by $1.9 million, or 8.2%, to $25.1 million during the first quarter of 2024, up from $23.2 million in the first quarter of 2023[110]. - Funds From Operations (FFO) increased by $1.0 million to $12.4 million during the first quarter of 2024, compared to $11.4 million in the first quarter of 2023[117]. Expenses and Financial Impact - Increased interest rates have significantly raised interest expenses, negatively impacting net income and cash provided by operations, as well as access to capital markets[100]. - Interest expense rose to $4.5 million in the first quarter of 2024, up from $3.7 million in the same period of 2023, primarily due to a $1.2 million increase in interest on the revolving credit agreement[118]. - The company experienced a reduction of $193,000 in building expenses related to vacant facilities, contributing to the overall increase in income[114]. Cash Flow and Financing Activities - Net cash provided by operating activities was $11.7 million during the first quarter of 2024, compared to $10.1 million in the same period of 2023, reflecting a $1.7 million increase[122]. - Net cash used in investing activities was $8.9 million in the first three months of 2024, compared to $5.4 million in the same period of 2023[122]. - The company declared and paid dividends of $10.0 million during the three-month period ended March 31, 2024, slightly up from $9.9 million in the same period of 2023[129]. - The company had $333.7 million of outstanding borrowings under its $375 million Credit Agreement as of March 31, 2024, with $41.3 million of available borrowing capacity[141]. - The company expects to finance all capital expenditures and acquisitions using internally generated funds and additional funds from its $375 million revolving credit agreement[133]. Operational Risks - The company faces risks from potential lease expirations and the inability of UHS to renew leases on hospital facilities, which could decrease future revenues[101]. - Legislative changes in the healthcare delivery system may adversely affect the operators of the company's facilities, including UHS[104]. - The nationwide shortage of clinical staff has led to increased labor costs for tenants, affecting their operational results and potentially impacting rental payments[101]. - The impact of the COVID-19 pandemic continues to pose uncertainties for the operations and financial results of the company's tenants[101]. - The company is exposed to cybersecurity threats, which could have a material adverse effect on its business and result in significant costs[104]. Financial Ratios and Metrics - The company’s total leverage ratio was 44.4% as of March 31, 2024, remaining below the covenant limit of 60%[144]. - The company’s fixed charge coverage ratio was 3.1x as of March 31, 2024, exceeding the required minimum of 1.50x[144]. - The tangible net worth was $187.8 million, down from $191.8 million on December 31, 2023[144]. - The secured leverage ratio stood at 4.0% as of March 31, 2024, compared to 4.1% on December 31, 2023, well below the 30% covenant threshold[144]. - The unencumbered leverage ratio increased to 45.2% as of March 31, 2024, from 44.2% on December 31, 2023, still under the 60% limit[144]. Mortgages and Debt - The company’s mortgages outstanding as of March 31, 2024, had a combined carrying value of approximately $32.7 million[145]. - The total outstanding mortgages as of March 31, 2024, amounted to approximately $32.7 million, down from $33.1 million on December 31, 2023[145]. - The combined fair value of the mortgages as of March 31, 2024, was approximately $30.7 million, compared to $31.2 million on December 31, 2023[145]. - The company had various mortgages secured by real property, with all being non-recourse[145]. Other Financial Information - The average effective interest rate for the revolving credit agreement was 6.96% in the first quarter of 2024, compared to 6.06% in the same quarter of 2023[118]. - The applicable margin over the adjusted term SOFR rate was 1.20% as of March 31, 2024[140]. - Off balance sheet arrangements included a cancellation of a $3.1 million letter of credit related to the Grayson Properties II construction loan as of March 31, 2024[146].